Ensign Peak Advisors’s Sana Biotechnology SANA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-72,050
Closed -$300K 1724
2024
Q3
$300K Buy
72,050
+4,000
+6% +$21K ﹤0.01% 1675
2024
Q2
$372K Buy
+68,050
New +$542K ﹤0.01% 1662
2023
Q1
Sell
-164,638
Closed -$650K 1786
2022
Q4
$650K Sell
164,638
-9,503
-5% -$46.5K ﹤0.01% 1509
2022
Q3
$1.04M Sell
174,141
-130,318
-43% -$940K ﹤0.01% 1043
2022
Q2
$1.96M Sell
304,459
-72,751
-19% -$463K ﹤0.01% 810
2022
Q1
$3.12M Sell
377,210
-4,983
-1% -$40.3K 0.01% 721
2021
Q4
$5.92M Sell
382,193
-234
-0.1% -$4.51K 0.01% 616
2021
Q3
$8.61M Sell
382,427
-6,362
-2% -$134K 0.02% 471
2021
Q2
$7.64M Buy
388,789
+18
+0% +$408 0.02% 507
2021
Q1
$13M Buy
+388,771
New +$12.7M 0.03% 372

Other funds holding SANA